We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-11.58%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.5M
AUM Growth
-$25B
Cap. Flow
-$1.87B
Cap. Flow %
-9,134.72%
Top 10 Hldgs %
15.16%
Holding
3,274
New
1,834
Increased
671
Reduced
618
Closed
49

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$75M
2
SBUX icon
Starbucks
SBUX
+$64.8M
3
BBY icon
Best Buy
BBY
+$59.8M
4
AME icon
Ametek
AME
+$59.7M
5
GD icon
General Dynamics
GD
+$58M

Top Sells

Rank Stock Value
1
GPC icon
Genuine Parts
GPC
+$579M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$578M
3
PAYX icon
Paychex
PAYX
+$403M
4
VMW
VMware, Inc
VMW
+$134M
5
RHT
Red Hat Inc
RHT
+$134M

Sector Composition

Rank Sector Weight
1 Technology 14.62%
2 Healthcare 13.9%
3 Financials 11.85%
4 Industrials 10.12%
5 Consumer Discretionary 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RACE icon
1176
Ferrari
RACE
$68.6B
$92 ﹤0.01%
+931
New +$105K
GG
1177
DELISTED
Goldcorp Inc
GG
$92 ﹤0.01%
9,457
-1,895
-17% -$18.4K
EXPE icon
1178
Expedia Group
EXPE
$35.5B
$91 ﹤0.01%
820
-19,793
-96% -$2.37M
RES icon
1179
RPC Inc
RES
$1.14B
$90 ﹤0.01%
9,144
+71
+0.8% +$965
RGEN icon
1180
Repligen
RGEN
$8.2B
$90 ﹤0.01%
1,719
-272
-14% -$16K
TMUS icon
1181
T-Mobile US
TMUS
$196B
$90 ﹤0.01%
+1,417
New +$95.1K
PRSP
1182
DELISTED
Perspecta Inc. Common Stock
PRSP
$90 ﹤0.01%
+5,312
New +$118K
ACAD icon
1183
Acadia Pharmaceuticals
ACAD
$4.45B
$89 ﹤0.01%
5,530
+1,475
+36% +$28.6K
WW
1184
DELISTED
WW International
WW
$89 ﹤0.01%
+2,325
New +$128K
CCEP icon
1185
Coca-Cola Europacific Partners
CCEP
$49.3B
$88 ﹤0.01%
+1,941
New +$89.9K
PBI icon
1186
Pitney Bowes
PBI
$2.41B
$88 ﹤0.01%
14,913
+513
+4% +$3.7K
FRC
1187
DELISTED
First Republic Bank
FRC
$88 ﹤0.01%
+1,014
New +$92.6K
NHY
1188
DELISTED
NORSK HYDRO A. S. ADR
NHY
$88 ﹤0.01%
19,505
+7,164
+58% +$32
ISRA icon
1189
VanEck Israel ETF
ISRA
$151M
$87 ﹤0.01%
+3,120
New +$97.1K
JKHY icon
1190
Jack Henry & Associates
JKHY
$11.2B
$87 ﹤0.01%
+688
New +$97.7K
RCL icon
1191
Royal Caribbean
RCL
$86.5B
$87 ﹤0.01%
903
-9,700
-91% -$1.06M
DOC icon
1192
Healthpeak Properties
DOC
$15.7B
$86 ﹤0.01%
+3,098
New +$85.8K
IX icon
1193
ORIX
IX
$42.8B
$86 ﹤0.01%
+6,010
New +$94.2K
NKTR icon
1194
Nektar Therapeutics
NKTR
$2.39B
$86 ﹤0.01%
+176
New +$106K
LPT
1195
DELISTED
Liberty Property Trust
LPT
$86 ﹤0.01%
+2,085
New +$90K
BNL
1196
DELISTED
BUNZL PLC ADS (RP 5 ORD SHS)
BNL
$86 ﹤0.01%
+2,879
New +$86
PBH icon
1197
Prestige Consumer Healthcare
PBH
$2.45B
$85 ﹤0.01%
+2,771
New +$101K
AKZOY
1198
DELISTED
Akzo Nobel NV
AKZOY
$85 ﹤0.01%
+3,187
New +$85
TWTR
1199
DELISTED
Twitter, Inc.
TWTR
$84 ﹤0.01%
+2,964
New +$92.9K
TRIP icon
1200
TripAdvisor
TRIP
$1.74B
$83 ﹤0.01%
+1,543
New +$85.4K
46 47
48
49 50

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Glenmede Trust held 3,274 positions worth $20.5M, down 100% from $25B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust withdrew a net $1.87B in Q4 2018, closing 49 positions and reducing 618 holdings. Its most notable exit was Andeavor, an estimated $48.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Cambrex Corporation worth $26.1K.

  • Glenmede Trust's largest Q4 2018 buy was Cambrex Corporation: 692,205 shares worth $26.1K.
  • Glenmede Trust added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $75M increase.
  • Glenmede Trust's biggest Q4 2018 reduction was Genuine Parts, cutting an estimated $579M.
  • Glenmede Trust fully exited Andeavor in Q4 2018, selling an estimated $48.2M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.5M portfolio in Q4 2018.
  • Glenmede Trust opened 1,834 new positions and closed 49 in Q4 2018.
  • Glenmede Trust's portfolio value fell 100% quarter-over-quarter to $20.5M.

Based on Glenmede Trust's 13F filing for Q4 2018, filed 14 Feb 2019.